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Periodontitis is an inflammatory disease of supporting tissues of the teeth 
caused by specific microorganisms resulting in the progressive destruction of 
periodontal ligament, alveolar bone with pocket formation, and recession or both1 
 The purpose of periodontal therapy is to eliminate the inflammation of the 
periodontal tissues and to regenerate the periodontal attachment apparatus including 
cementum, functionally oriented periodontal ligament and alveolar bone.2  
 In general, Regeneration is defined as “Reproduction or reconstitution of a lost 
or injured tissue”.3 ‘Periodontal regeneration’ is defined histologically as 
“Regeneration of tooth’s supporting structures including alveolar bone, periodontal 
ligament and  cementum over a diseased root surface”.3 Thus the key to periodontal 
regeneration is to stimulate the progenitor cells to reoccupy the defects.4         
 Conventional periodontal treatments such as scaling and root planing are 
highly effective in repairing disease related defects and halting the progression of 
periodontitis. These treatments typically result in the development of long junctional 
epithelium between the root surface and gingival connective tissue rather than 
regrowth of tissue that restores the architecture and function.5   
 For decades, a number of surgical procedures have been advocated which 
includes open flap debridement, open flap debridement with bone grafts or bone 
substitutes and guided tissue regeneration. Open flap debridement may result in the 
formation of long junctional epithelium which is more susceptible to microbial 
invasion and is thought to be less stable attachment. Thus bone grafting is the most 
common form of regenerative therapy.3,6 Autogenous bone grafts, bone derivatives 
(Allogenic grafts, Xenogenic grafts) and bone substitutes (Alloplastic materials) have 
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been used for periodontal regeneration. The use of these bone grafts results in the 
regrowth of alveolar bone and formation of new attachment which would be 
stimulated either by osteogenesis, osteoconduction, or osteoinduction.7  
 Among all these biomaterials autogenous bone grafts have been adopted as 
gold standard since there is possibility to retain cell viability, graft revascularization 
and no possibility of disease transmission.6 Also they were considered to yield high 
osteogenic potential and used with the intent to improve the outcomes of periodontal 
regeneration.5 These bone grafts contain live osteoblasts and osteoprogenitor cells and 
heal by osteogenesis.7, 8  
 Autogenous bone grafts can be harvested either from intraoral or extraoral 
donor sites. Multiple intraoral locations have been used to harvest bone grafts, 
including the maxillary tuberosity, exostoses, extraction sites and edentulous ridges. 
Another important source of intraoral autogenous bone grafts includes the harvesting 
of osseous coagulum, bone blend generated from osteoplasty or ostectomy.8, 9   
 The osseous coagulum is obtained by mixing the bone dust and blood. This 
produces small particle size which induces more bone formation and provides 
additional surface area for the interaction of vascular and cellular elements.10 
Recently, the autogenous bone scraper which is used in periodontics produces osseous 
coagulum of thin curled bone strips.10,11 This scraper is more advantageous compared 
to other intraoral harvesting methods as it eliminates the need for second surgical site, 
and reduced postoperative pain and swelling and thus ultimately improves patient 
morbidity.12 
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 The major disadvantages of autografts are donor site morbidity, procurement 
techniques, handling and processing of the harvested material, which have led to the 
introduction of allografts.13 Allografts also may result in the transmission of 
pathogens. Their high cost and the shortage of supply of donor bone resulted in the 
introduction of Xenografts.13 Xenograft is prepared by protein extraction of bovine 
bone that results in trabecular structure of hydroxy apatite similar to human 
cancellous bone. It enhances the rate of bone formation by osteoinduction, and seems 
to be compatible since its use has not been associated with any immunological 
reaction. 7, 14  
 Allografts, Xenografts, Alloplasts donot possess inherent osteogenic 
properties and act only as a substrate for cell migration and proliferation and this led 
to the application of various biologically active substances such as peptide sequences, 
protein preparations, and polypeptide growth factors to enhance regeneration in both 
bone and periodontal defects.15 Polypeptide growth factors are biologic mediators that 
regulate cellular events including cell proliferation, chemotaxsis, differentiation and 
matrix synthesis via binding to specific surface receptors.15, 16 
 Growth factors may be preserved in platelets. Platelets contain factors such as 
Platelet deriver growth factor (PDGF), Transforming growth factor- β (TGF-β), 
Vascular endothelial growth factor (VEGF), Insulin growth factor (IGF), Hepatocyte 
growth factor, Epidermal growth factor and these factors are involved in angiogenesis 
and osteogenesis.16 Amongst these growth factors PDGF and TGF- β have been 
extensively studied and are known to be abundant in the alpha granules of platelets.17  
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 A convenient approach to obtain autologous PDGF and TGF - β is the use of 
autologous platelet concentrate also known as Platelet Rich Plasma (PRP). PRP is a 
highly concentrated form of autogenous platelets and works via the degranulation, 
providing a rich and readily obtainable source of diverse group of   growth factors.17,18 
These growth factors are concentrated to about 300 times than that of level normally 
present in plasma. 18 The use of PRP is based on its potential to release multiple 
wound healing growth factors and cytokines, which are responsible for increasing cell 
mitosis, increasing collagen production, recruiting other cells to the site of injury, 
initiating vascular in-growth and inducing cell differentiation.19  
 PRP stimulates fibroblastic and osteoblastic proliferation and suppresses 
epithelial cell proliferation.18,20  PRP is believed to result in early consolidation and 
graft mineralization to increase the rate of bone formation and also promote 15–30 % 
increase in trabecular bone density.21 Thus PRP could be an attractive and potent 
material for bone graft procedures as it has the ability to form hydrogel, suitable for 
cellular migration, and proliferation. Also the local concentration of secreted growth 
factors in PRP enhances the initial wound healing.21  
 Thus in the present study a combination of PRP and Xenograft is compared 
with Autogenous bone graft with respect to clinical and radiological findings after a 
period of six months in periodontal intrabony defects. 
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AIMS & OBJECTIVES 
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 The aim of the present study is to compare Autogenous bone graft (Group 1) 
and Xenograft combined with PRP (Group 2). The clinical and radiological 
parameters were evaluated after a period of six months in periodontal intrabony 
defects. 
The parameters for assessing the effectiveness of grafts are 
1. Evaluation of change in probing depth following therapy. 
2. Estimation of change in clinical attachment level following therapy. 
3. Evaluation of amount of bone fill following therapy. 
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Periodontal regeneration : 
 The goal of tissue engineering and regenerative therapy is to promote healing 
and regeneration of tissue’s structure and function.22 Regenerative treatment 
modalities includes the use of three – dimensional biomaterial scaffolds or matrices to 
support the regeneration of tissues lost due to diseases. Thus the important goal of 
periodontal therapy is to obtain a reduced pocket depth after treatment in order to 
arrest further disease progression.23, 24    
Cell types and molecules participating in periodontal regeneration : 
1. Cells  
a. Epithelial – Junctional epithelium. 
b. Fibroblasts – Gingival fibroblasts, Periodontal ligament fibroblasts. 
c. Bone cells – Osteoblasts, Osteoclasts, Osteocytes. 
d. Cementoblasts. 
2. Molecules 
a. Growth factors – Fibroblast growth factors (FGF) 1and 2, Insulin like growth (IGF) 
factors I and II, BMP’s, Epidermal growth factor (EGF), Platelet derived growth 
factor (PDGF) 
b. Adhesion molecules – Fibronectin, laminin, Osteopontin, collagens. 
c. Structural proteins – Type I, III, V, XII, XIV Collagens.19 
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         Melcher A.H (1976) stated that regeneration of the periodontal ligament is the 
key to new attachment because, it provides continuity between the alveolar bone and 
cementum and contains cells that can synthesize and remodel the three connective 
tissues of the periodontium.3 He also stated that the types of cell which repopulate the 
root surface after periodontal surgery determines the nature of attachment that would 
eventually form. After periodontal flap surgery, the debrided root surface may be 
repopulated by four different types of cell: Epithelial cells, Cells derived from the 
gingival connective tissue. (gingival fibroblasts), Cells derived from the bone 
(osteoblasts,osteoclasts), Cells derived from the periodontal ligament (periodontal 
ligament fibroblasts).3 
Osseous defects : 
 Osseous defects can be classified into infrabony and suprabony defects. An 
infrabony defect is a type of osseous defect in which its base is apical to the crestal 
margin of the alveolar bone. Vertical defects or angular defects are those that occur in 
an oblique direction leaving a hollowed out trough in the bone along the side of the 
root.1 
 Goldman HM and Cohen DW (1958)25 classified angular defects on the basis 
of the number of walls: 
· Three wall defect : 
One in which the defect has three bony walls and the tooth constitutes the fourth wall. 
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· Two wall defect : 
 One in which the defect is delineated by two bony walls and a root surface. 
· One wall defect : 
 One in which only one bony wall and the root surface remain. 
 Glickman I and Carranza FA added one more type of angular defect to 
Goldman and Cohen’s classification and called it the combined osseous defect: 
where the number of walls in the apical portion of the defect could be greater than that 
in its occlusal portion.1 If an infrabony defect is present, there is a net loss of the 
attachment apparatus ie; bone, periodontal ligament and cementum. Intrabony defects, 
especially the three-wall defect, provide the best opportunity for regaining the lost 
periodontal attachment by using bone substitutes.1, 5    
Bone grafts : 
               Bone grafting is usually done to establish a new attachment apparatus at a 
more coronal level than that existing in a particular diseased tissue.26 Grafting 
biomaterials include autogenous grafts, allogenic grafts, xenogenic grafts and 
alloplastic materials. The assumption behind the clinical use of grafting procedures is 
that the complete regeneration of the attachment apparatus including new bone 
formation and new connective tissue attachment would be enhanced by the various 
biomaterials due to their osteogenetic potential, osteoinductive capability, or 
osteoconductive properties.7 Osteogenesis refers to the formation or development of 
new bone cells contained in the graft. Osteoinduction is a chemical process by which 
molecules contained in the graft convert the neighboring cells into osteoblasts. 
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Osteoconduction is a physical effect by which the matrix of the graft forms a scaffold 
that favours outside cells to penetrate the graft and form new bone.26  
          Bowers GM, Chadroff B, and Carneval R (1989)24 evaluated the new 
attachment apparatus formation in humans and the value of graft materials in 
enhancing the formation of new bone, cementum, and periodontal ligament. Biopsies 
were obtained at 6-months and evaluated. Results indicated that a significantly more 
new attachment apparatus, new cementum and new bone formed in grafted than 
nongrafted sites. They concluded that the combination of highly osteogenic materials 
and epithelial exclusion techniques offer promise for enhancing the amount, 
frequency and predictability of periodontal regeneration. 
          Aichelmann-Reidy ME, Yukna RA et al. (1998)26 reviewed about the various 
bone substitutes in the treatment of intrabony defects. The results showed that 
significant reduction in clinical probing depth and improved gain in attachment levels 
compared to flap debridement surgery alone for periodontal osseous defects. 
          Reynolds MA, Elizabeth M (2003)8 reviewed the efficacy of bone replacement 
grafts in the treatment of periodontal osseous defects. The results showed that bone 
grafts increases bone fill, reduces crestal bone loss, increases clinical attachment level 
and reduces probing depth compared to open flap debridement. Histologically they 
concluded that new attachment apparatus was observed in intrabony defects following 
bone grafting where as open flap debridement resulted in repair characterized by the 
formation of long junctional epithelium.  
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Autogenous bone grafts: 
              The use of bone grafts for reconstructing osseous defects produced by 
periodontal disease dates back to Hegedus in 1923 and was revieved by Nabers & 
O’Leary in 1965.27 Multiple grafting materials have been used to clinically improve, 
via regeneration, the prognosis of teeth within intrabony defects. Among them, 
autogenous bone is regarded as the gold standard for bone regeneration, due to its 
intrinsic characteristics that provide optimal conditions for angiogenesis and 
migration of cells with osteogenic potential. The autogenous bone graft in contrast to 
both allografts and xenografts has osseoinductive, osseoconductive properties and is 
immunologic free.6  
Sources of Autografts: 
 The only materials with human histological evidence to substantiate their 
regenerative use are autogenous bone grafts that can be harvested from either intraoral 
or extraoral donor sites. Multiple intraoral locations have been used to harvest bone 
grafts, including the maxillary tuberosity, exostoses, healing wounds and extraction 
sites and edentulous ridges. Another important source of graft material includes the 
harvesting of osseous coagulum, bone blend generated from osteoplasty or 
ostectomy.7,8 Robinson E first described the technique of osseous coagulum by 
mixing the bone dust and blood. This produces small particle size which induces more 
bone formation and provides additional surface area for the interaction of vascular and 
cellular elements.10 
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 Thus many investigators have reported on the clinically successful use of 
autogenous bone grafts harvested from intraoral sites in the treatment of intrabony 
defects. It yields regenerative responses superior to those obtained following surgical 
debridement procedures alone.8 Moreover, long-term evaluations suggest that the 
regenerative gain achieved by autogenous bone grafts remains clinically stable.28  
 Robinson E et al. (1968)10 conducted an in vivo study to evaluate the potential 
of Osseous coagulum for bone induction. He used high speed turbines in conjunction 
with carbide burs to obtain osseous coagulum. The patient had a 7 mm pocket on the 
mesial aspect of a mandibular second premolar and osseous coagulum was grafted. At 
three months pocket depth reduced to 2-3 mm. Reentry procedures after 3, 4, 6, 12, 18 
and 24 months showed considerable amount of bone fill. They also concluded that the 
smaller the particle size of the donor bone, the more certain are its resorption and 
replacement. 
  Schallhorn RG, and Denv MS (1968)29 studied the use of autogenous hip 
marrow biopsy implants for bony crater defects. They selected patients with 
moderately advanced periodontitis localized or multiple interproximal bony crater 
defects of 4 to 5 mm apical to the crests of the facial and lingual bony plates. On 
reflaping the areas, it was apparent that the defects were completely filled with 
osseous tissue. Thus they concluded that autogenous bone can be successfully used 
for the eradication of interproximal bony crater defects. 
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  Robinson E (1969)30 used osseous coagulum for bone induction in which they 
mixed autogenous cortical bone chips with blood and placed in periodontal defects.  
He concluded that smaller particle size of the donor bone leads to rapid resorption and 
replacement of host bone and thus osteogenesis occurs at a rapid rate. 
         Halliday DG et al.  (1969)31 grafted newly formed autogenous bone in the 
osseous defects. The donor site he preferred was edentulous area of the mandible. He 
then treated mandibular first molar with pocket depth of 7 mm in 3 patients with 
intraoral cancellous autogenous bonegrafts. He concluded that in all 3 cases, the bone 
in the area of reattachment is more radiolucent than the surrounding bone and showed 
complete success in attaining reattachment after 9 months.  
 Rivault A, Toto P, Garguilo A et al (1971)32 studied the histologic healing 
phenomena in periodontal defects corrected by the osseous coagulum procedure in 4 
adult rhesus monkey. The defects between first and second premolars and second 
premolar and first molar were grafted with intraoral autografts. They concluded that 
osteogenic stimulus which induce the undifferentiated mesenchymal cells to become 
osteoblasts, originates in the osseous walls of the defects as well as on the graft 
material. The graft material undergoes necrosis and its components appear to be used 
for the build up of new bone.  
 Haggerty PC, Maeda I et al. (1971)9 treated 10 vertical bone defects with 
autogenous bone grafts. They concluded that autogenous bone grafts can be used 
successfully in the surgical armamentarium to restore the attachment apparatus around 
periodontally diseased teeth. 
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 Hiatt W, Schallhorn RG, and Aaronaian RJ (1972)33 transplanted intraoral 
cancellous bone and marrow which was taken from maxillary tuberosity area into 166 
periodontal osseous defects in 40 patients. They concluded that an average bone fill of 
3.44 mm was obtained. The greatest fill came from those defects with great number of 
bony walls. The cancellous bone has considerable surface area and more number of 
osteoclasts when compared to iliac marrow. There is no evidence of root resorption 
while using intraoral autografts. 
   Coverly L, Toto P, and Garguilo A (1975)34 histologically evaluated the 
regeneration of osseous coagulum in surgically created 2 and 3 wall defect of 4 young 
adult female rhesus monkey and grafted those sites with osseous coagulum. They 
concluded that the use of osseous coagulum led to a more rapid osteogenesis 
compared to correction by curettage alone.  
 Forum SJ, Thaler R, Scopp IW et al. (1975)35 studied about the histological 
responses of osseous coagulum in 3 patients with infrabony defects. Histologic 
findings were obtained from the grafted site 6-13 weeks postoperatively and 
concluded that remodeling involved the osseous walls, periodontal ligament (PDL), 
cementum and graft spicules. Also there is marked increase in cementogenesis at the 
grafted sites.   
 Hawley CE, Miller J (1975)36 showed that 28 months following free osseous 
autograft therapy, microscopically the periodontal structures were reconstructed with 
new bone, PDL and cementum and also found that osteogenesis occurred at a rapid 
rate. 
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           Carraro JJ, Sznajder N and Alonso CA (1976)2 treated 56 infrabony pockets 
with one wall and two wall bony defects with intraoral cancellous bone and 44 defects 
were treated with open curettage without bonegrafts. They concluded that more 
favourable results (new attachment) were obtained in treatment of infrabony pockets 
when intraoral cancellous bone is used in association with conventional techniques of 
flap surgery compared to open curettage alone. Also observed that, in 2 wall bony 
defects the use of bonegrafts results in a greater area of new attachment. 
             Hiatt W, Schallhorn RG, Aaromain RJ et al.  (1976)37 studied the 
microscopic examination of human bone marrow allograft and autograft in 100 
human block section.They concluded that both allografts and autografts yielded new 
attachment apparatus including new cementum, bone and functionally oriented PDL. 
Also no ankylosis or root resorption was noted in fresh intraoral donor material and 
with frozen iliac autografts.  
          Mellonig JT (1991)14 reviewed the treatment of bone autografts and allografts 
in periodontal therapy. The various graft materials were discussed with respect to case 
reports, controlled clinical trials, and human histology. The study concluded that 
autogenous bone grafts can be used successfully in periodontal therapy. Also multiple 
histologic reports suggest that regeneration of a new attachment apparatus is possible 
with different types of autogenous bone grafts. Root resorption and ankylosis may be 
observed only following grafts of fresh iliac cancellous bone and marrow.  
               Becker W, Burton et al.  (1998)38 compared Demineralized Freeze-Dried 
Bone Allografts (DFDBA) and autogenous bone in human extraction sockets. 7 
patients were selected and biopsy done between 3-13 months. The study concluded 
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that DFDBA sites revealed the presence of dead particles with no evidence of 
osteoclastic resorption and appear to delay normal bone formation. Autologous sites 
revealed vascular channels with woven lamellar bone and were undergoing active 
osteoclastic resorption. 
          Erpenstein H, Diedrich P et al. (2001)39 evaluated the performance of two 
bone mills (R Quetin Bone Mill and Micro Knochenmühle, Aesculap) for the grinding 
of autogenous bone (intraoral, cortical) according to the following criteria: (1) loss of 
bone during the grinding process, (2) particle size of the chips, (3) variability in chip 
size, (4) technical handling, and (5) cost-benefit ratio. The size and variability of the 
bone particles were determined histomorphometrically. They concluded that, to 
promote osteogenetic activity, small particles of graft were considered as the best. The 
Quetin mill was superior in all points to the Aesculap mill for the requirements of a 
periodontal practice. 
            Cochran DL, Jones A, Heijl L et al (2003)40 evaluated the periodontal 
regeneration with a combination of enamel matrix proteins and autogenous bone 
grafts. Periodontal defects ranging in size from 1-6 mm were selected. The results 
showed that enamel matrix proteins plus autogenous bone grafts treatment resulted in 
greater tissue formation than controls. They concluded that enamel matrix proteins 
and autogenous bone represents a therapeutic approach that can be highly effective in 
stimulating significant amounts of periodontal regeneration. 
            Choi CS, Chai CS, and Wikesijo (2005)6 evaluated the periodontal healing 
with focus on root resorption and ankylosis following implantation with autogenous 
bone and coral derived biomaterial in intrabony defects in dogs. After 8 weeks 
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histological analysis done and concluded that particulated autogenous bone and coral 
derived biomaterial may be implanted into periodontal defects without significant 
healing observation such as root resorption and ankylosis. 
                  Orsini M, Orsini G et al. (2008) 41 studied the long term clinical results on the 
use of autogenous bone grafts in the treatment of intrabony defects. They compared 
the use of autografts with calcium sulfate and autografts covered with membrane.12 
subjects were selected in the spilt mouth trial. The results showed that, at 6 months 
there was a probing depth reduction and improved clinical attachment level in both 
the groups. Thus they concluded that both therapies led to significant short and long 
term improvement in the outcome variables and autogenous bone grafts appears to 
have a valuable role in treating periodontal defects.  
           Abolfazli N, Saber FS,   Lafzi A,  Eskandari A et al.  (2008)11 conducted a 
study to compare cerabone (A Decalcified Freeze-dried Bone Allograft) with 
Autogenous Bone Graft (ABG) in the treatment of two and three-wall intrabony 
periodontal defects. A total of 5 patients with 10 pairs of intrabony defects received 
surgical therapy. 10 sites were treated with DFDBA and 10 sites were treated with 
ABG. After 6 months bone fill and defect resolution significantly improved in both 
groups. The study concluded that both graft materials were beneficial for treatment of 
intrabony defects. 
 Sangeetha singh (2010)42 conducted a study to evaluate the regenerative 
potential of intra-oral autogenous bone grafts in the treatment of intrabony defects in 
patients with generalized aggressive periodontitis. The study concluded that 
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autogenous bone grafts produced a significant probing depth reduction and bone fill at 
6 months. 
Bone substitutes: 
             Bone substitutes will play a pivotal role in the future of periodontal 
regeneration. They are synthetically derived or processed from exoskeletons of other 
species (xenograft) and are an alternative to autogenous or allogeneic bone 
replacement grafts.7 The main concerns over autogenous graft are related to donor site 
morbidity and graft resorption, and these have triggered the development of new 
conceptual grafting approaches in order to provide efficient alternatives to autogenous 
bone, either of fill bone gaps or to attain large bone augmentations.8 Also the quality 
of autogenous bone is variable depending on the health status of the patients who are 
in greatest need of the best material to promote regeneration. Even in healthy patients, 
the disadvantages of a limited supply, increased procedure time and post operative 
pain and risk of surgical complications at the harvest sites led to the substantial effort 
to develop an off-the-shelf autograft substitute.14 These includes allogenic, xenogenic, 
synthetic graft materials which function primarily by passively guiding or conducting 
cell migration through the matrix, eventually leading to repair of the defect.26 
           Osteoinduction is the formation of new bone by inducing the differentiation of 
undifferentiated mesenchymal cells through stimuli provided by the demineralized 
bone matrix. The process of osteoinduction requires the presence of a collagen or 
proteoglycan matrix and bioactive proteins such as Bone Morphogenic protein 
(BMP).43 Osteoinductive potential of commercially available DFDBA is subject to the 
bioavailability of BMP in its active form. BMP has been shown to up regulate the 
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expression of cbfa-1128 -the master switch that regulates osteoblast differentiation. 
BMP exerts its effects primarily through the Smad pathway although other 
mechanisms have been suggested. A truly inductive material must be capable of 
supporting the differentiation of uncommitted bone marrow stromal cells to osteoblast 
for optimal bone regeneration in periodontal defects.14, 44 
             Bowers GM, Granet M, Stevens M (1985) 45 evaluated the potential for 
regeneration of a new attachment in patients whose attachment apparatus had been 
destroyed by periodontal disease. Debrided intrabony defects were treated with and 
without demineralized freeze-dried bone allograft. Biopsies were obtained in 6 
months and regeneration was evaluated histometrically. Preliminary results in 7 
patients and 24 intrabony defects indicate that new attachment was observed when 
intrabony defects were grafted with demineralized freeze-dried bone allograft. New 
attachment was not observed in nongrafted sites.  
                Sonis ST, Williams RC, Marjorie K et al. (1985)46 Studied histologically, 
clinically and radiographically to evaluate the sequence of healing following 
implantation of bovine demineralized bone powder (DBP) into severe, spontaneous 
periodontal defects in beagle dogs. No evidence of localized inflammatory response 
or delayed hypersensitivity reaction was noted. Histologic evaluation demonstrated 
the presence of DBP at 1 month following implantation, but the material was replaced 
with new bone by 3rd month. An intact epithelial attachment appeared  at the 1st month 
after the implantation of DBP. They concluded that DBP did not appear to predispose 
to external root resorption and successfully induced new bone formation. 
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           Reynolds MA and Bowers GM (1996) 5 observed histologically the fate of 
DFDBA in human intrabony defects. Histologic sections showed defects harboring 
residual graft particles exhibited significantly greater amounts of new attachment 
apparatus formation including new bone, cementum, and associated periodontal 
ligament than sites without evidence of graft matrix. 
         Fucini SE, Quintero G et al. (1993)47 compared the bony defect resolution 
obtained using two different particle size ranges of DFDBA. Paired interproximal 
intrabony periodontal defects in 11 patients were grafted with DFDBA. Soft and hard 
tissue measurements were made using an electronic constant-force probe at the initial 
and reentry surgeries. Treated sites in 10 patients were reevaluated by reentry 
approximately 6 months postoperatively. Mean bony defect fill was 1.66 mm for the 
large particle group and 1.32 mm for the small particle group. There was no 
statistically significant difference in bony fill between defects grafted with the 
different particle sizes of DFDBA when used in humans. 
              Brunsvold MA, Mellonig JT et al (2000)48 did a study to evaluate bovine 
derived xenograft in the treatment of human periodontal defects. 4 patients with 
radiographic evidence of vertical bone loss were selected and grafted with bovine 
derived xenograft. After 6 months block sections were taken. Histologically they 
found the formation of new bone, cementum, and PDL, coronal to the base of the 
reference point. Thus the study concluded that periodontal regeneration is possible 
following grafting bovine derived xenograft. 
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Growth factors: 
                The lack of a predictable outcome when using passive therapies, such as 
osteoconductive matrices and guided tissue regeneration, led to the development of 
treatments designed to stimulate the cells responsible for regeneration.19 The tissue 
engineering combines three key elements to enhance regeneration: conductive 
scaffolds, signaling molecules and cells.19 The important biological event involved in 
tissue regeneration is specific cell directed migration.19 A variety of naturally 
occurring potent bioactive proteins are known to be present in bone, platelets, and a 
number of other cells and tissues and these regulates events in tissue engineering.49  
             Polypeptide growth factors (PGF) are naturally occurring biological modifiers 
that have the potential to alter the host tissue to stimulate or regulate the wound 
healing process. They regulate key cellular events in tissue regeneration, including 
cell proliferation, chemotaxsis, differentiation, and matrix synthesis via binding to 
specific cell surface receptors.49 Growth factors either singly or in combination have 
been used and experimental evidence for bone regeneration has been documented in 
both animal and human trials.50 
              Terranova VP and Wikesjo (1987)51 reviewed extracellular matrices and 
polypeptide growth factors as mediators of functions of cells of the periodontium. The 
polypeptide growth factors are hormone-like in both structure and function. Factors 
which modulate cell chemotaxis have recently been implicated in cellular growth and 
differentiation. In addition, endothelial cell growth factor has been shown to be a 
potent chemoattractant for human endothelial cells while platelet-derived growth 
factor has been shown to be a chemoattractant for smooth muscle cells and 
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fibroblasts. Thus, the study concluded that both PGFs and isolated components of the 
extracellular matrix appear to play an increasingly important role in our understanding 
of tissue definition. 
           Committee on Research, Science and Therapy of American Academy of 
Periodontology (1996)52 is intended for members of the dental profession. They 
reviewed the various aspects of Growth factors (GFs) on cells and tissues involved in 
periodontal wound healing. According to them growth factors are a class of biological 
mediators involved in repair and regeneration, regulates several key cellular processes 
such as mitogenesis, chemotaxis, differentiation, and metabolism. The sequence of 
events necessary for periodontal regeneration relies on the above processes for 
osteogenesis, cementogenesis, and connective tissue formation. They concluded that 
numerous preclinical in vitro and in vivo studies have demonstrated that certain 
growth factors modulate putative components of periodontal wound healing resulting 
in substantial regeneration of the periodontium in animals. 
Platelet Rich Plasma: 
              Platelets are a rich source of naturally occurring growth factors, which can 
play an important role in regeneration of periodontal tissue. PRP is procured from 
whole blood and is rich in platelets and naturally occurring autologous growth factors 
that are present in plasma.17,53 Its use is based on the potential of the plasma to release 
multiple wound-healing growth factors and cytokines, which are responsible for 
increasing cell mitosis, increasing collagen production, recruiting other cells to the 
site of injury, initiating vascular in-growth and inducing cell differentiation.57 
Released growth factors such as PDGF, TGF-β, IGF and EGF have been shown to 
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have an osteoregenerative potential because of their pro-angiogenic effects and 
differentiating effects on osteoblasts. Recently, a combination of PRP and bone graft 
has been advocated as a means of increasing the rate of osteogenesis and enhancing 
bone formation qualitatively. Moreover, it has been suggested that PRP may promote 
a 15% to 30% increase in the trabecular bone density.15  
Contents of PRP: 
 The large numbers of platelets found in PRP release significant quantities of 
mitogenic polypeptides, such as PDGF, TGF-β, as well as IGF-I.17  
Platelet derived growth factor: 
 Platelet derived growth factor is a glycoprotein with a molecular mass of 
approximately 30kDa. It is the primary growth factor in platelets, and also synthesized 
and secreted by other cells such as macrophages and endothelial cells.16 The PDGF 
family consists of four members, PDGF-A, PDGF-B and newly identified PDGF-C 
and PDGF-D, which form four functional homodimers, PDGF-AA, PDGF-BB, 
PDGF-CC, PDGF-DD as well as heterodimer  PDGF-AB, as endogenous cell 
products. PDGF-A, PDGF-B chains are expressed on most cell types such as 
fibroblasts, osteoblasts, endothelial cells and macrophages, and PDGF-C, PDGF-D 
are expressd in various tissues. There are approximately 0.06 ng of PDGF per 1 
million platelets. This calculates to 6×10gram of PDGF, or about 1200 molecules of 
PDGF, per individual platelet.17, 53  
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  It stimulates chemotaxis of fibroblasts, neutrophils and macrophages. 
Activates macrophages, induce proliferation of fibroblasts and stimulates the 
production of the extracellular matrix components, fibronectin.54 PDGF is responsible 
for mitogenesis, causing an increase in number of healing cells, angiogenesis, 
generating development of new capillaries and up regulation of other growth factors 
and cells resulting in promotion of fibroblastic and osteoblastic functions, promotion 
of cellular differentiation, and acceleration of the effects of growth factors on other 
cells.17 
Transforming Growth Factor –β: 
             Transforming growth factor-β is a term applied to a super family of growth 
factors and differentiating factors of which the bone morphogenetic proteins (BMPs) 
are members. The three isoforms of TGF-b (b1, b2 and b3) have a broad range of 
activity within healing. TGF-b1 is the most abundant in all tissues and is the form 
found in platelets.17 It is chemotactic for monocytes, lymphocytes, and fibroblasts. It 
stimulates endothelial cell proliferation and tubule formation. TGF-β plays a central 
role in regulating maturation and strength of wounds.55 
Insulin like growth factors: 
             Insulin-like Growth Factor-I (IGF-I) and Insulin-like Growth Factor-II (IGF-
II) are usually thought of as growth factors secreted by osteoblasts during bone 
formation to increase numbers of osteoblasts and thereby accelerate bone deposition. 
Both IGF-I and IGF-II are relatively small proteins with molecular masses of 7.7kd 
and 7.5kd, respectively. They bind to a specific IGF cell membrane receptor that 
excites kinase activity (formation of a high-energy phosphate bond) to a cytoplasmic 
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signal protein. IGFs are released to couple new bone formation to bone resorption. 
The presence of IGF in platelets would be expected to act on precursors of osteoblasts 
i.e., those cells already committed to an osteoblast lineage and on endosteal 
osteoblasts, which are the cells that produce the initial phase I bone in bone grafts. 
Insulin-like growth factors are therefore mitogenic to osteoblast lineage cells and are 
also stimulators of bone formation from existing differentiated osteoblasts.17 
Platelet derived epidermal growth factor (PDEGF): 
            PDEGF was discovered by Cohen in 1962 and was the first growth factor 
described. It stimulates epidermal regeneration, promotes wound healing by 
stimulating the proliferation of keratinocytes and dermal fibroblasts and enhances the 
effects and production of other growth factors.17,56 
Platelet derived angiogenesis factor (PDAF): 
           PDAF has the capacity to induce vascularization in vivo. It stimulates vascular 
endothelial cells and is involved in the process by which new blood vessels invade 
devascularized tissue. 17, 56 
Platelet factor-4 (PF-4): 
           PF – 4 is a chemoattractant for neutrophils released from alpha granules, which 
may be partially responsible for the influx of neutrophils into wounds. It acts as 
chemoattractant for fibroblast and is a potent anti-heparin agent.17 
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Harvesting or Procurement of PRP: 
            Several recent studies have highlighted different methods to harvest PRP and 
its numerous advantages I the healing of bone, bone grafts and soft tissue. 
The Automated Systems: 
           A number of methods make the use of electronic gradient density 
centrifugation for separation of blood and plasma. 
           Marx et al (1998)17 in a study obtained PRP by means of an electromedics 
gradient density cell separator. This cell separator withdraws 400-450 ml of venous 
blood via venous catheter. With a centrifuge speed of 5600 rpm, blood is with drawn 
at a rate of 50ml/min as the separator adds citrate phosphate dextrose at 1:5 ml ratio. 
Blood is centrifuged into three basic components i.e. red cells, PRP (buffy coat) and 
Platelet poor plasma (PPP). Once PPP is collected, the centrifuge speed is reduced to 
2400 rpm to allow for precise separation of PRP and PPP. To initiate the coagulation 
process PRP is mixed with 10% calcium chloride and 10,000 units of bovine 
thrombin. The resultant gel was mixed with bone graft and packed into the recipient 
site. Platelets counts showed an increase of 338% in PRP compared to baseline count. 
            Juan Obarrio and Jose Dutare (2000)15 in a case report on growth factors in 
periodontal surgery, used the ELMD-500 medtronics transfusion system for procuring 
PRP. 
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The Test tube or Manual isolation techniques (Vacuatainer system): 
            The test tube method contained a lower concentration of platelets compared to 
the automated system, it was the most economical and contains adequate amount of 
growth factors namely, PDGF-AB, PDGF-BB, TGF-β. 
             Sonnleitner and Sullivan (2000)58 presented a simplified technique for 
producing PRP for intraoral grafting techniques using The Test tube or Manual 
isolation techniques (Vacuatainer system). 6ml of blood was collected in a test tube 
containing anticoagulant and centrifuged for 20 minutes at 1200 rpm. This results in 
two layers i.e, lower opaque red cell fraction also containing WBCs and Platelets and 
a second upper straw yellow turbid fraction called the serum component. Then the 
entire serum component was pipetted out. Test tube was centrifuged again for 15 
minutes at 2000 rpm. This resulted in the formation of a platelet concentration (PRP) 
and the resulting supernatant PPP. The top 80% of PPP was pipetted out. The residual 
PRP was mixed with 0.1 ml of thrombin and 10% calcium chloride to procure the gel. 
             The test tube method has also been advocated by Landesberg59 and 
Glickman 2000, Aghaloo and Freymiller 2002, Kim and Park 2002, Weibrich G 
2002. 
               Thus the incorporation of platelet rich plasma (PRP) with bone graft 
produces dense, vital bone in a shorter interval. The growth factors has been shown to 
accelerate bone repair, promote fibroblast proliferation, increase tissue vascularity, 
rate of collagen formation and mitosis of mesenchymal stem cells and endothelial 
cells, as well as osteoblasts, thus  playing key roles in the rate and extent of bone 
formation.54 
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            Matsuda N, Cho I, Genco RJ et al.  (1992)60 did an in vitro study to evaluate 
the mitogenic, chemotactic and synthetic responses of rat PDL fibroblastic cells to 
EGF, TGF -β, rh PDGF-AB,  rh PDGF-BB, natural (n) PDGF –AB and  IGF. The 
maximum mitogenic effect of PDGFs were observed at the concentrations at 10ng/ml, 
where as IGF-I was seen at concentration higher than 100ng/ml. TGF- β, showed 
inhibitory mitogenic responses. The study concluded that rh PDGF-BB, IGF-I 
stimulate proliferation and chemotaxsis of PDL fibroblastic cells. rh PDFG-AB also 
stimulates collagen synthesis by PDL fibroblastic cells. Thus rh PDGF-BB and IFG-1 
may have important roles in promotion of PDL healing and may be useful for clinical 
application in periodontal regeneration.  
           Oates TW, Rouse CA, Cochran DL et al. (1993)61 conducted in vitro study to 
determine the effects of PDGF on human PDL cells. The results of the study 
demonstrated that both PDGF AA & BB enhance the mitogenic activity in a dose 
dependent manner over a concentration range of 1-5 mg/ml. They concluded that 
PDGF – AA and BB are major mitogens for human PDL cells.  
           Marx RE, Carlson, Ralph M, and Eichstaedt (1998)17 used autologous platelet 
concentrates to identify the growth factors present within them. The additional 
amount of these growth factors obtained by APC to grafts evidenced a radiographic 
maturation 1.62 to 2.16 times that of grafts without APC as assessed by histometry 
and radiographic evidence.  
            Mccauley LK, Somumam MJ et al. (1998)16 studied about the biologic 
modifiers in periodontal regeneration. They suggested that many of the biologic 
modifiers mainly growth factors like PDFG, TGF- β,  have significant influences on 
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cell behaviour and show great promise for use in regenerative therapies. Also they 
discussed that the additional investigations are required both at the molecular level 
and at clinical level to improve the predictability of regenerative therapies. 
 Moonti-Cho (1998)63 studied the effect of platelet derived growth factor in 
guided tissue regenerative therapy. The lesions selected were protected by an 
expanded polytetrafluroethylene barrier membrane and PDGF - BB. The study 
concluded that the application of PDGF-BB showed potent chemotactic and 
mitogenic effects on PDL fibroblasts. The sustained release of PDGF – BB also 
contributes to the repopulation of fibroblast synthesis of extracellular matrix 
components in the wound. 
              De Obarrio JJ, Arauz-Dutari JI, Chamberlin TM et al. (2000) 15 conducted 
an in vitro study to demonstrate a new biotechnology in which platelet gel is used in 
combination with demineralized freeze dried bone allograft for treatment of 
periodontal osseous defects. 5 patients with serve localized bone loss were treated 
with PRP and DFDBA. Evaluation at 2nd and 6th months they found significant 
reduction in probing depth. Also the reentry at 2 years revealed significant bone fill of 
the periodontal osseous defects. New bone formation was evident and confirmed by 
IOPA. Thus they concluded that new biotechnology significantly enhanced 
periodontal regeneration and wound healing.  
   Shanaman R, Flistein MR, Danesh-Meyer MJ et al. (2001)63 did a study to 
evaluate the potential of PRP in combination with bone allograft to enhance bone 
regeneration in alveolar ridge defects. Augmentation resulted in clinical and 
radiographic gain in both vertical and horizontal components of osseous defects. They 
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suggested that PRP used in conjugation with various bone derivatives can support 
new bone formation in localized alveolar ridge defects. PRP also improved the 
handling properties of the graft material with which it was combined, thereby 
facilitating graft placement and stability. 
              Lekovic, Camargo PM, Weinlaender M, Vasilic N et al. (2002)64          
conducted a study to compare the effects of PRP / BPBM / GTR and GTR alone. 
They selected 18 systemically healthy patients having two similar interproximal 
defects with pocket depths of 6 mm and defects were surgically treated with an 
absorbable membrane GTR or a combination of PRP / BPBM / GTR. At 6 months 
pocket depth reduction was 4.98 for PRP / BPBM / GTR and 3.62 mm for GTR. The 
gain in clinical attachment observed was 4.37 mm for PRP / BPBM / GTR and 2.31 
mm for GTR groups. PRP and BPBM provides an added regeneration effect to GTR 
in promoting the clinical attachment of intrabony defects. 
                Okuda K, Kawase T, Momose M et al. (2003)65 conducted in vitro study to 
demonstrate that PRP contains high levels of PDGF and TFG- β. Evaluation for 
PDGF – AB and TGF- β1 was done using ELISA kits. The results showed the levels 
of PDGF-AB and TGF- β1 were 182 ng/ml and 140 ng/ml respectively. The study 
concluded that PRP can serve as a source for the GFs such as PDGF and TGF- β. In 
addition PRP also modulates cell proliferation and suppresses epithelial cell 
proliferation. The suppression of the downgrowth of junctional epithelium onto the 
dental root surfaces in the regeneration process would avoid interference by 
epithelium with the formation of new connective tissue attachment on the root surface 
and thus clinical application of PRP act as a potent tool to facilitate periodontal 
regeneration.  
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 Hanna R, Trejo M and Weltman RL (2004)20 conducted randomized, spilt 
mouth clinical trial to compare the clinical outcomes obtained by the combination of 
PRP and Bovine derived xenograft (BDX) to those obtained from the use of the bone 
replacement graft alone in the treatment of intrabony defects. 13 patients with 
attachment loss of ≥ 6 mm were selected. At 6 months probing depth reduction of 
3.54 mm and 2.53 mm obtained in BDX with PRP and BDX alone respectively. The 
study concluded that addition of high concentration of autologous platelets to BDX to 
treat intrabony defects significantly improved their clinical periodontal response. 
            Quyang Xiang Ying, Qiao Jing et al.  (2006)66 evaluated the effectiveness of 
PRP as an adjunct to bovine porous bone mineral (BPBM) graft in the treatment of 
human intrabony defects. 10 patients with intrabony defects > 6mm were selected. 5 
defects were treated with BPBM alone in split mouth design. After 1 year Probing 
depth reduction was 4.78mm in BPBM / PRP and 3.48 mm in BPBM alone. CAL 
gain is about 4.52mm, 2.85 mm in BPBM /PRP and BPBM respectively.  The study 
concluded that additional biological effects of PRP may contribute to the 
improvement of clinical outcome in the combined group (PRP+BPBM). The secreted 
GFs immediately bind to their transmembrane receptors on adult mesenchymal stem 
cells, osteoblasts, fibroblasts, endothelial cells and cause cellular proliferation, matrix 
formation, osteoid production and collagen synthesis. Thus a combination of PRP and 
BPBM led to us significantly more favourable clinical improvement in periodontal 
intrabony defects compared to BPBM alone.  
  Torres J, Tamimi F, Tresguerres IF et al. (2009)67 conducted a study to 
evaluate the combination of anorganic bovine bone graft (ABB) with PRP. 16 healthy 
6 months old female rabbits were used and created calvarial defects were grafted with 
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ABB or PRP or ABB with PRP. 6 weeks after augmentation, mixture of PRP with 
ABB produced twice the vertical bone volume of ABB alone. Thus the study 
conducted that the combination of anorganic bovine bone and PRP resulted in 
increased vertical bone augmentation when compared with autologous blood in 
similarly sized created defects.  
           Ogino Y, Ayukawa Y, Kukita T et al. (2009)68 conducted an in vivo study to 
evaluate the effects of PRP and PPP on osteoclastogenesis with rat bone marrow cell 
culture. The results showed that PRP decreased the number of TRAP positive 
multinucleated cells in a dose-dependent manner and also the amount of 
osteoprotegerin produced from rat bone marrow cells. They concluded that that PRP 
suppresses osteoclastogenesis, therefore inhibiting bone resorption. In addition they 
also demonstrated that PRP increased the secretion of osteoprotegerin, an inhibitor for 
osteoclast formation. 
         Creeper F, Lichanska AM, Marshall RI et al (2009)69 aimed to investigate the 
in vitro effect of PRP on osteoblasts and periodontal ligament cell function. PRP is 
used to deliver growth factors, in a safe and convenient manner for enhancing bone 
and periodontal regeneration. The results showed that PRP and PPP had stimulatory 
effects on the migration and cellular proliferation of both human osteoblasts and 
periodontal ligament cells. They concluded that PRP can exert a positive effect on 
osteoblast and periodontal ligament cell function. PPP also appears to have the ability 
to promote wound healing-associated function. 
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 Nagata, Melo (2009)70  histologically analysed the effect of autogenous 
platelet-rich plasma (PRP), on healing of autogenous bone (AB) grafts placed in 
surgically created critical-size defects in rabbit. The results showed that AB and 
AB/PRP significantly improved bone formation and a beneficial effect of PRP was 
limited to an initial healing period of 4 weeks. 
 Kotsovilis S, Markou N, Pepelassi E et al. (2010)71 conducted randomized 
controlled clinical trials (RCTs) to evaluate the adjunctive use of PRP in the therapy 
of periodontal intraosseous defects.  Data sources were obtained from electronic 
databases, manually searched journals and contact with experts. They concluded that 
the clinical use of PRP is an entirely safe procedure, causing no adverse events or 
postoperative complications. Diverse outcomes (positive and negative) have been 
reported for the efficacy of PRP combined with various therapeutic bioactive agents 
or procedures, reflecting the limited and heterogeneous data available and possibly 
suggested that the specific selection of agents or procedures combined with PRP 
could be important. Additional research on the efficacy of each specific combination 
of PRP is necessary. 
  
 
 
 
 
  36
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
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 A randomized, split mouth, single evaluator; 6 months prospective clinical 
study was conducted to evaluate the clinical and radiographic parameters in 
periodontal intrabony defects using autografts and xenografts with PRP. Prior to 
initiating the study the patients were informed of the purpose and design of this 
clinical trial and were requested to sign an informed consent for the study. The ethical 
clearance was obtained from the institutional ethical board. Patients were selected 
from out patient Department of Periodontics, J.K.K. Nattaraja dental college and 
Hospitals, Komarapalayam using the following selection criteria. 
 Inclusion criteria:  
1. Age limit of 20-50 years of both sexes. 
2. Probing depth  ≥ 5mm as assessed by William’s graduated periodontal probe.  
3. Patients with a minimum of two contralateral intrabony defects. 
4. Vital teeth. 
Exclusion criteria:  
1. Known systemic diseases, short and long term drug therapies. 
2. Drug allergies. 
3. Pregnant and lactating women. 
4. Teeth with traumatic occlusion. 
6. Smokers. 
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STUDY DESIGN: 
       A split mouth design was followed, where two sites in the contra lateral 
quadrants with probing pocket depth of  ≥ 5mm with radiographic evidence of bone 
loss at baseline were chosen. Probing pocket depth standardization was done with 
acrylic stent in all the selected areas. 
CRITERIA FOR GROUPING 
  Group1: 7 intrabony defects treated with autogenous bone grafts. 
  Group2: 7 intrabony defects treated with xenogenic grafts and PRP. 
CLINICAL PARAMETERS 
      The following variables were measured at baseline, 3 months & 6 months post 
surgery. 
1. Gingival index  
2. Plaque index 
3. Oral hygiene index (simplified) 
4. Probing pocket depth - deepest probing depth was measured. 
5. Clinical attachment level. 
1) Gingival Index: (Loe. H and Silness. P, 1963) 
The soft tissue surrounding each tooth were divided into 4 gingival scoring 
units i.e. the distofacial papilla, the facial margin, the mesiofacial papilla and the 
entire lingual margin. A periodontal probe was used to assess the bleeding of the 
gingival tissues on probing. 
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Gingival units were assessed according to the following criteria: 
0 -   Normal gingiva 
1 - Mild inflammation, slight change in color, slight edema, no bleeding on 
palpation. 
2 - Moderate inflammation, redness, edema & glazing, bleeding on probing. 
3 -Severe inflammation, marked redness & edema, ulceration, tendency for 
spontaneous bleeding. 
        The gingival index score for each of the 4 gingival surfaces was given a score 
from 0 to 3. The scores around each tooth were totaled and divided by four and the 
gingival index score for each tooth was obtained.  
The scoring criteria are as follows 
0.1 – 1.0 -Mild 
1.1 – 2.0 -Moderate. 
2.1 - 3.0 - Severe. 
2) Plaque index: (Silness. P and Loe. H, 1964) 
0 - No plaque in the gingival area. 
1 - A film of plaque adhering to the free gingival margin and adjacent area of 
the tooth. The plaque may be recognized only by running a probe across the 
tooth surface. 
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2 - Moderate accumulation of soft deposits within the gingival pocket & on 
the gingival margin or adjacent tooth surface that can be seen by the naked 
eye. 
3 - Abundance of soft matter within the gingival pocket or on the gingival 
margin & adjacent tooth surface.  
        The areas examined were distofacial, facial, mesiofacial and lingual surface, 
using explorer. The plaque score was obtained by totaling the four plaque scores per 
tooth and then divided by four. The plaque score per person is obtained by adding the 
plaque score per tooth and dividing by the number of teeth examined. 
The scoring criteria are as follows 
          0.1 -1.7 - Good.  
          1.8 - 3.4 - Fair. 
          3.5 – 5.0 - Poor.  
3) Oral hygiene index (Green & Vermillion 1964): 
        The six tooth surfaces were examined. Facial surface of 16, 11, 26, 31 and 
lingual surface of 36, 46 were examined using an explorer.  
Debris index (DI - S) 
       Dental explorer was placed on the incisal third of the tooth and moved towards 
the gingival third of the tooth.  
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The scoring criteria is  
0 - No debris or stain present. 
1 -Soft debris covering not more than 1/3rd of the tooth surface or the 
presence of extrinsic stains without other debris, regardless of surface area 
covered. 
2 -Soft debris, covering more than 1/3rd but not more than 2/3rd of exposed 
tooth surface. 
3 -Soft debris covering more than 2/3rd of the exposed tooth surface. 
DI - S score per person is obtained by totaling the debris score per tooth 
surface & divided by number of surfaces examined. 
Calculus index: (CI – S) 
 Assessed by placing a dental explorer into the distal gingival crevice and 
drawing it sublingually from distal contact area to the mesial contact area. 
0 – No calculus present. 
1– Supragingival calculus covering more than 1/3rd of the exposed tooth 
surface. 
2-Supragingival calculus covering more than 1/3rd but not more than 2/3rd of 
the exposed tooth surface, or the presence of the individual flecks of 
subgingival calculus around the cervical portion of the tooth or both. 
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3- Supragingival calculus covering more than 2/3rd of the exposed tooth 
surface or a continuous heavy band of subgingival calculus around the cervical 
portion of the tooth or both. 
The clinical level of DI, CI are 
Good - 0.0 - 0.6 
Fair -   0.7 - 1.8 
Poor - 1.9 – 3.0 
The OHI-S score per person is the total of DI-S and CI -S scores per person. 
The scoring criteria are as follows 
0.0 - 1.2 - Good 
1.3 – 3.0 - Fair 
3.1 – 6.0 - Poor 
4) Probing pocket depth: 
            The depth of the pocket was measured at selected sites using William’s 
graduated periodontal probe. The probe was inserted parallel to the long axis of the 
tooth gently, until resistance was felt and the readings were recorded to the nearest 
millimeter from the gingival margin to the base of the pocket. Acrylic stents were 
used to standardize the path of insertion and angulation of the probe. 
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5) Clinical attachment level: 
  The level of attachment is the distance between the base of the pocket and 
Cementoenamel Junction (CEJ) or a fixed point. The distance from the CEJ (if CEJ is 
not detected, the coronal border of the stent was used) to the base of the pocket was 
measured. The readings were recorded to the nearest millimeter.  
          Occlusal stents for positioning and measuring probes were fabricated with cold 
cured acrylic resin on a cast model obtained from an alginate impression. Notch was 
made on the stent to permit and standardize the entry of periodontal probe into the 
pocket. The occlusal stent was made to cover the occlusal surfaces of the tooth being 
treated and occlusal surface of one tooth in the mesial and distal directions. The stents 
were also extended apically on the buccal and  lingual surfaces to cover the coronal 
third of teeth involved. 66, 72 
RADIOGRAPHIC PARAMETERS: 
 An intraoral periapical radiograph (IOPA) of each defect site was exposed. 
Exposure was made at 226 volts at 0.6 second and Kodak E – speed plus films were 
used. The film to object and focal spot to object distances were standardized to 20cm. 
Digitized images were displayed on the monitor at 5X magnification using Adobe 
Photoshop 7.0 computer software. A 0.5mm grid was made on the digitized images 
and all linear measurements were made using Auto-CAD 2006 software.73 
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PRESURGICAL THERAPY: 
 For all the enrolled patients routine blood investigations were taken. The 
initial therapy consisted of oral hygiene instructions, scaling & root planing. Three 
weeks following phase I therapy, a periodontal re-evaluation was performed. The 
study used a split mouth design where two interproximal sites were assigned to PRP 
and Xenograft or Autogenous bone graft. 
PRP preparation: 
 10ml of blood was drawn from patients by a venipuncture of the antecubital 
vein 30 minutes prior to surgery. Blood was transferred to a sterile glass tube 
containing the anti-coagulant (3.8% sodium citrate). The test tube was gently shaken 
so that blood and anticoagulant got thoroughly mixed. The initial centrifugation 
process was done at 1200 r.p.m for 15 minutes at room temperature.66 This results in 
separation of 2 basic fractions, 
1. Lower opaque red cell fractions containing White blood cells, Platelets and 
red cells. 
2. Upper straw yellow turbid fraction which is the serum.  
 Serum is then pippetted out into new test tube and the remaining red cell 
fraction is centrifuged at 2000 rpm for 20 minutes. The second centrifugation results 
in 
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1. Platelet poor plasma (PPP) on the top of the preparation which contains 
few platelets. 
2. Middle layer comprising of PRP which consists of platelets and White 
blood cells.  
3. Bottom most fraction comprising of red blood corpuscles which also 
contains newly synthesized platelet at the top most layer. 
              80% of PPP was pipetted out and discarded. PRP was then pippetted along 
with some red blood cell fraction and collected in a separate sterile glass tube.66  
SURGICAL PROCEDURES: 
 All the periodontal surgical procedures were performed on patients under   
aseptic conditions by a single operator following presurgical phase. The patient was 
anaesthetized using lignocaine 2% with 1:1,00,000 epinephrine as a vasoconstrictor. 
Using Bard – Parker blade number 15 buccal and lingual sulcular incisions were made 
to elevate the mucoperiosteal flaps. Pocket epithelium and granulation tissue from the 
inner surface of flaps were carefully removed. Thorough soft tissue debridement & 
root planing were accomplished with Hu - Friedy curettes. The surgical area was then 
rinsed with copious amounts of sterile saline. 
Surgical procedure for Group 1: 
                With the autogenous bone scraper (Ebner grafter, Salvin Dental Specialists, 
USA) bone shavings were obtained from the site adjacent to the defect area. The 
curved blade shaves bone when raked with appropriate pressure and angled at 25-30 ْ
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from the bone surface with a pull stroke, produces very thin curled bone strips. These 
bone shavings were collected in a collection chamber. While scraping, shavings 
combine with blood and flow into collection chamber forming osseous coagulum. 
Later the collected autogenous bone graft was grafted in the intrabony defect. 
Surgical procedure for Group 2: 
                  PRP was mixed with 10% calcium chloride to facilitate coagulation and to 
activate platelets before application. Osseograft (Advanced Biotech Products (P) Ltd 
India) is a demineralized bone matrix composed of type I collagen derived from 
bovine cortical bone samples (Xenograft), and particles of approximately 250 
micrometers. Osseograft was emptied into a sterile dappen dish and PRP was added 
until the mixture becomes applicable. Increments of the graft material were added, to 
the bottom of the defect, and were condensed with an amalgam condenser to adapt the 
particles to the defect until it was completely filled. After grafting, flaps were 
repositioned to accomplish as much as possible complete inter proximal closure. The 
flaps were approximated with simple interrupted sutures using 3-0 silk thread. Post 
surgical instructions (Appended) were given to the patient and recalled after one week 
for suture removal and follow up.  
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APPENDIX-1 
Instructions to the Patient 
1. Report immediately on developing any untoward reactions like pain, swelling, 
hypersensitivity, drug allergies. 
2.   Should   report to the dental office if secondary bleeding persists within 24 
hours. 
3.  Should avoid intake of any hot and hard foods. 
4.   Patient was advised to take antibiotic every 8 hours for 3 days and analgesic 
every 12 hours. 
5.  Avoid brushing the treated area for 1 week from the day of surgery; use cotton tip 
applicator (Johnson and Johnson ear buds) to gently clean the area. 
6.  Not to use dental floss and toothpicks at the site. 
7.   0.12%chlorhexidine mouth rinse twice daily. 
8.  Follow up visits have  to be done in 24 and 48 hours. 
9. The patients were asked to perform regular oral hygiene habits by appropriate 
brushing technique using tooth brush and tooth paste.  
10. The patients were instructed to report on the subsequent appointment.  
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APPENDIX-2 
PROFORMA 
PATIENT NAME:                                                                              OP NO: 
AGE:                                                                                                    SEX: 
ADDRESS:                                                                                          PHONE NO: 
 
CHIEF COMPLAINT: 
 
 
              
SITE SELECTED:    
 
 
 GROUP 1:    (AUTOGRAFTS)    
                  
 
 GROUP 2:   (XENOGRAFT+PRP) 
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INDICES 
GINGIVAL INDEX 
BASELINE: 
                                                                                 
          D    M                                     M       D
    
     
            
 8           7     6        5        4         3       2       1        1         2        3       4       5        6         7        8
                                                                                                                                                                                                  
    
          
         Score 
3 MONTHS:                                                                          
                                                                                 
          D    M                                     M       D
    
     
            
 8           7     6        5        4         3       2       1        1         2        3       4       5        6         7        8
                                                                                                                                                                                                  
    
          
         Score 
6 MONTHS:                                                                          
            D    M                                     M       D
    
     
                  
           8           7     6        5        4         3       2       1        1         2        3       4       5        6         7        8 
 
 
         Score
B 
P 
B 
L 
B 
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B 
L 
B 
P 
B 
L
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PLAQUE INDEX 
BASELINE: 
                                                                                 
          D    M                                     M       D
    
     
            
 8           7     6        5        4         3       2       1        1         2        3       4       5        6         7        8
                                                                                                                                                                                                  
    
          
         Score 
3 MONTHS:                                                                          
                                                                                 
          D    M                                     M       D
    
     
            
 8           7     6        5        4         3       2       1        1         2        3       4       5        6         7        8
                                                                                                                                                                                                  
    
          
         Score 
6 MONTHS:                                                                          
  D    M                                     M       D
    
     
                  
           8           7     6        5        4         3       2       1        1         2        3       4       5        6         7        8 
 
 
         Score 
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L
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ORAL HYGIENE INDEX 
Debris index (DI) 
                BASELINE:   
                      16        11        26        
       
   
    
      
                          46          31          36                                         SCORE                 
 
3RD MONTH: 
                           16          11        26 
      
   
    
      
                           46          31           36                                             SCORE                                   
6TH MONTH: 
                      16       11          26 
      
   
    
      
                            46        31           36                                                 SCORE                            
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Calculus  index (DI) 
                BASELINE:   
                       16        11        26        
       
   
    
      
                          46          31          36                                         SCORE                 
 
3RD MONTH: 
                             16          11        26 
      
   
    
      
                           46          31           36                                             SCORE                                   
6TH MONTH: 
                      16       11          26 
      
   
    
      
                            46        31           36                                                 SCORE                            
OHI SCORE (DI+CI) = 
INTERPRETATION: 
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CLINICAL PARAMETERS:  
DATA BASELINE 3 RD  MONTH 6 TH MONTH 
 
GROUP 1 GROUP 2 GROUP 1 GROUP 2 GROUP 1 GROUP 2 
Probing pocket 
Depth (mm) 
      
Clinical 
Attachment 
Level (mm)  
      
 
RADIOGRAPHIC FINDINGS: 
 
DATA 
BASELINE 3 MONTHS 6 MONTHS 
 
GROUP 1 
 
GROUP 2 
 
GROUP 1 
 
GROUP 2 
 
GROUP 1 
 
GROUP 2 
Bottom of  the 
defect to CEJ 
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INFORMED CONSENT OBTAINED FROM THE PATIENT 
DEPARTMENT OF PERIODONTICS , J .K .K NATARAJA DENTAL COLLEGE , 
KOMARAPALAYAM, NAMAKKAL DISTRICT. 
PATIENT NAME: 
I have been explained about the nature and purpose of the study in which, I 
have been asked to participate. I understand that I am free to withdraw my consent 
and discontinue at any time without prejudice to me or effect on my treatment. 
I have been given the opportunity to question about the material and study. I 
have also given the consent for photographs to be taken at the beginning, during and 
end of the study. I agree to participate in this study. 
I hereby give the consent to be included in “COMPARITIVE ANALYSIS OF 
CLINICAL AND RADIOLOGICAL PARAMETERS OF INTRABONY DEFECTS 
TREATED WITH AUTOGRAFT AND XENOGRAFT COMBINED WITH PRP”. 
 
Station:                                                                      SIGNATURE OF PATIENT 
 
Date:                                                                         SIGNATURE OF PROFESSOR 
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                                                  APPENDIX-3 
                                            ARMAMENTARIUM 
MATERIALS AND INSTRUMENTS USED FOR PERIODONTAL FLAP 
SURGERY: 
 Gloves 
 Mouth mask 
 Patient apron 
 Chair apron 
 Head cap 
 Sterile cotton rolls 
 Gauze 
 Saline 
 Kidney tray 
 Betadine 
 Lignocaine 
 Syringe 
 Mouth mirror 
 Straight Probe 
 Explorer 
 William’s graduated periodontal probe 
 Tweezer 
 Tissue holding forceps 
 Bard-Parker handle 
 Bard-Parker blade number:11, 15 
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 Periosteal elevator 
 Hu-Friedy Gracey Curettes 
 Ultrasonic scalers 
 Needle holder 
 3-0 silk suture 
 Scissors 
 Dappendish 
 Autogenous bone scraper (Ebner grafter - Salvin Dental Specialists, USA) 
 Osseograft (Advanced Biotech Products (P) Ltd India) 
 Plastic instrument 
 Amalgam condenser. 
MATERIALS AND INSTRUMENTS FOR PRP PREPARATION 
 10 ml Syringe 
 Torniquet 
 Pippettes 
 Test tubes 
 Centrifuge (R8C laboratory centrifuge, Remi equipments, Mumbai) 
 Calcium chloride 
 Anti-coagulant 
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RESULTS 
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 In this study Student t – distribution (William Sealy Gosset) is used to 
analyze the significance between the groups at different time intervals. 
 The t –distribution is used when the sample size is small (less than 30) and 
standard deviation of the population is unknown.  
Paired t -Test:  
When there is a direct relationship between each specific data point in the first 
and second set, such as measurements on the same subject before and after the study, 
then the paired t-test will be appropriate. 
 According to this test,  
               The t – statistic is defined as 
                              
21
2121
nn
nn
S
XXt +×
−=
 
1X  - mean of the first sample. 
2X  - mean of the second sample. 
1n  - number of observations in the first sample. 
2n - number of observations in the second sample 
S - combined standard deviation. 
Thus  
         p<0.001 was considered as highly significant at 1% level of significance. 
         p>0.05 was considered as not significant at 5% level of significance. 
  59
Plaque index (PI): 
         The mean plaque index score at baseline was 1.14 ±0.68, at 3rd month was 
0.80±0.52 and at 6th month was 0.51±0.42. The values at 3rd and 6th month were not 
statistically significant when compared to baseline; with a p-value >0.05 as shown in 
Table no.1 and Graph no.1. 
Oral hygiene index (OHI): 
            The mean oral hygiene index score at baseline was 1.04±0.70, at 3rd month 
was 0.72±0.52 and at 6th month was 0.52±0.42. Comparing with the baseline value, it 
was not statistically significant at 3rd and 6th month time intervals with a p-value 
>0.05 as shown in Table no.1 and Graph no.1. 
Gingival index: 
  At baseline the mean gingival index score was 1.02±0.53, reduced to 
0.73±0.48, 0.42±0.32 at the end of 3 months and 6 months respectively. The values at 
3rd and 6th month were not statistically significant when compared to baseline with a 
p-value >0.05 as shown in Table no.1 and Graph no.1. 
Probing pocket depth (PPD): 
            In Group 1, at baseline the mean probing pocket depth was 7.85±0.89 mm, 
reduced to 5.14±0.75 mm at 3rd month and 3.86±0.90 at 6th month.  In Group 2, at 
baseline it was 7.67 ±0.80 mm, that reduced to 5.26±1.20 mm at 3rd month and 
4.57±0.55 mm at 6th month as shown in Table no.2 and Graph no.2. In Group 1, the 
percentage (%) of PPD reduction was 34.52%, 50.82% at the end of 3rd and 6th month 
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respectively. In Group 2, it was 31.42% at 3rd month and 40.41% at 6th month as 
shown in Table no.5 and Graph no.5. On comparison between Group 1 and Group 2 
from baseline to 3rd and 6th month, statistically it was highly significant with             
p-value <0.001.  
Clinical attachment level (CAL): 
           In Group 1, the mean CAL at baseline was 8.71±0.94 mm, at the end of 3rd 
month the gain was 6.14±1.49 mm and at 6th month was 4.57±1.30 mm. In Group 2, 
the mean CAL at baseline was 8.28±0.60 mm, at the end of 3rd month was 6.83±1.32 
mm and at 6th month was 5.82±1.12 mm as shown in Table no.3 and Graph no.3. In 
Group 1, the % of gain at 3rd month was 29.50% and at 6th month was 47.53%. In 
Group 2, at 3rd month it was 17.51% and at 6th month was 34.54% as shown in Table 
no.5 and Graph no.5. On comparison from baseline, the gain in CAL between the 
Groups at 3rd and 6th month time intervals were statistically highly significant with p-
value <0.001. 
Bone fill: 
            In Group 1, the defect at baseline was 7.57 ±0.75 mm. The bone fill was 
6.33±1.11 mm and 4.42±0.53 mm at 3rd and 6th month respectively. In Group 2, the 
defect at baseline was 7.71 ±0.94 mm. The bone fill was 6.71±0.75 mm and 
5.57±0.97 mm at 3rd and 6th month respectively as shown in Table no.4 and Graph 
no.4. The % of bone fill in Group 1 at baseline was 0%, at the end of 3rd month it was 
16.38% and at the end of 6th month was 46.60%. In Group 2, at baseline it was 0 %, at 
3rd month was 12.91% and at 6th month was 27.7% as shown in Table no.5 and Graph 
no.5. Comparing the mean defect fill between the Groups at 3rd and 6th month, 
statistically it was highly significant with p-value < 0.001. 
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TABLES 
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TABLE – 1 
Comparison of mean plaque index scores, oral hygiene index scores, gingival 
index scores at baseline 3months and 6 months 
 
PARAMETERS 
 
BASELINE 
 
3 MONTHS 
 
6 MONTHS 
 
p - value 
 
 Plaque index 
 
1.14 ±0.68 
 
0.80±0.52 
 
0.51±0.42 
 
>0.05* 
 
 
Oral hygiene index 
 
1.04±0.70 
 
0.72±0.52 
 
0.52±0.42 
 
>0.05* 
 
 
 
Gingival index 
 
1.02±0.53 
 
0.73±0.48 
 
0.42±0.32 
 
>0.05* 
 
 
    *    p- value between baseline, 3months and 6months is >0.05 denotes                            
not statistically significant at 5% level. 
TABLE – 2 
Inter group difference in mean probing pocket depth (PPD) 
at baseline 3months and 6 months 
 
PROBING POCKET   
DEPTH 
 
GROUP 1 
(Mean±SD) 
 
GROUP 2 
(Mean±SD) 
 
p – value 
 
Baseline 
 
7.85 ±0.89 
 
7.67 ±0.80 
 
< 0.001** 
 
3 months 
 
5.14 ±0.75 
 
4.86±1.20 
 
< 0.001** 
 
6 months 
 
3.86±0.90 
 
4.57±0.55 
 
< 0.001** 
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TABLE - 3 
Inter group difference in mean clinical attachment level (CAL) at baseline 
3months and 6 months 
 
 
CLINICAL 
ATTACHMENT 
LEVEL 
 
GROUP 1 
(Mean±SD) 
 
GROUP 2 
(Mean±SD) 
 
p – value 
 
Baseline 
 
8.71 ±0.94 
 
8.28 ±0.60 
 
< 0.001** 
 
3 months 
 
6.14±1.49 
 
6.83±1.32 
 
< 0.001** 
 
6 months 
 
4.57±1.30 
 
5.42±1.12 
 
< 0.001** 
 
 
TABLE - 4 
Inter group difference in mean bone fill at baseline 3months, and 6 months 
 
 
DEFECT 
 
GROUP 1 
(Mean±SD) 
 
GROUP 2 
(Mean±SD) 
 
P   Value 
 
Baseline 
 
7.57 ±0.75 
 
7.71 ±0.94 
 
< 0.001** 
 
3 months 
 
6.33±1.11 
 
6.71±0.75 
 
< 0.001** 
 
6 months 
 
4.42±0.53 
 
5.57±0.97 
 
< 0.001** 
 
              ** p- value between baseline, 3months and 6months is < 0.001 denotes                            
statistically highly significant at 1% level 
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TABLE - 5 
Inter group difference in percentage (%) of PPD reduction, CAL gain, and 
bone fill at baseline 3months and 6 months 
 
PARAMETERS 
GROUP 1 GROUP 2  
p-value 3 months 6 months 3 months 6 months 
 
 PPD reduction 
 
34.52±0.14 
 
50.82±0.15 
 
31.42±0.5 
 
40.41±0.31 
 
<0.001** 
 
 
 CAL  gain  
21.58±0.40 
 
47.53±0.38 
 
17.51±0.86 
 
34.54±0.40 
 
<0.001** 
  Bone  fill  
16.38±0.48 
 
46.60±0.29 
 
12.91±0.19 
 
27.7±0.03 
 
<0.001** 
 
 ** The overall comparisons were highly significant at 1% level of significance   
(p<0.001) 
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GRAPHS 
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GRAPH‐1 
Comparison of mean changes in plaque index, gingival index, 
Oral hygiene index at baseline, 3months and 6 months 
 
GRAPH‐2 
Comparison of mean changes in probing pocket depth (PPD) 
between the groups at baseline 3months and 6 months 
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GRAPH‐3 
Comparison of mean changes in clinical attachment level (CAL) 
between the groups at baseline, 3months, and 6 months 
 
GRAPH ‐4 
Comparsion of mean bone fill between the groups in 
baseline, 3 months and 6 months 
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GRAPH‐5 
Comparsion between the groups in percentage of PPD reduction, 
CAL gain, bone fill at 3 months 
0
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GRAPH‐6 
Comparsion between the groups in percentage of probing 
depth reduction, attachment gain, bone fill at 6 months 
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DISCUSSION 
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 Periodontal disease is characterized by the presence of gingival inflammation, 
periodontal pocket formation, loss of connective tissue attachment and loss of alveolar 
bone around the affected teeth.73 The treatment of these periodontal diseases by 
traditional methods may result in healing by the formation of long junctional 
epithelium.3 Hence regenerative procedures have focused on the regeneration of new 
attachment apparatus including cementum, periodontal ligament and alveolar bone.3,4 
Autografts, allografts, xenografts and alloplasts are the most commonly used bone 
grafts in regenerative therapy.7, 8 
 Autogenous bone has been used with success and may be harvested from intra 
or extra-oral sites. Though the outcome of iliac grafts in many cases was very 
positive, complicated harvesting procedure, the need for hospitalization, donor site 
morbidity, potential ankylosis and root resorption were a few drawbacks.74  
 To overcome these drawbacks of extra-oral autografts, the present study 
utilizes intra-oral autogenous bone grafts obtained by Ebner grafter (Salvin Dental 
Specialists, USA) which is more advantageous as it eliminates the need for second 
surgical site, and reduces the post operative pain and swelling.12 
In the present study autogenous bone graft was compared clinically and 
radiographically with demineralized freeze dried bone xenograft (Osseograft) 
combined with PRP in the treatment of human intrabony periodontal defects.  
 In the present study at baseline, mean plaque index scores, oral hygiene 
index scores and gingival index scores were found to be 1.14 ±0.68, 1.04±0.70 and 
1.02±0.53 respectively. All these values reduced to 0.51±0.42, 0.52±0.42 and 
0.42±0.32 respectively at the end of 6 months. The changes at different time intervals 
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(3rd and 6th months) was not statistically significant (p-value >0.05) but marked 
improvement in clinical parameters were observed. These results concur with the 
studies done by Gupta et al. (2007) 72 who observed marked improvement in the 
clinical parameters in terms of plaque index and gingival index after periodontal 
therapy. According to Gupta et al. (2007) 72 the patients undergoing periodontal 
therapy will maintain optimal oral hygiene and their compliance led to the 
improvement in their plaque index and gingival index scores.  
The baseline mean probing pocket depth (PPD) in Group 1 was 7.85±0.89 
mm, and at the end of 6 months the mean PPD was 3.86±0.90 mm. And so the 
reduction in PPD was 3.99 mm was obtained in Group 1. Similar results were 
reported by Halliday et al. (1969) 31 who observed probing pocket depth reduction of 
4 mm following treatment of intrabony defects with intaoral autogenous bone grafts. 
 In Group 2, the mean probing pocket depth reduced from 7.67 ±0.80 mm to 
4.57±0.55 mm at the end of 6 months. Thus the PPD reduction of 3.10 mm was 
obtained in Group 2. This is in accordance with Hanna et al. (2004) 20 who showed 
that xenografts combined with PRP resulted in greater probing pocket depth reduction 
of  3.5 mm compared to xenografts alone.  
In Group 1 the PPD reduction at the end of 6 months was 50.82%. In Group 2 it 
was 40.41%. The overall comparison between Group 1 and Group 2 were statistically 
highly significant with p-value <0.001. This is in agreement with Coverly, Toto et al. 
(1975) 34 who reported that the earlier occurrence of osteogenesis in the osseous 
coagulum grafted defects resulted in higher pocket depth reduction compared to 
xenografts. This rapid filling of the osseous defects may also serve to inhibit the 
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apical migration of the epithelial attachment during the early stages of repair, thereby 
inhibit the subsequent recurrence of the defect.34 
In this study both the Groups 1 and 2 resulted in a significant attachment gain at 
the end of 6 months compared to baseline. In Group 1, the mean gain in CAL at the 
end of 6 months was 3.14 mm. A study conducted by Halliday (1969) 31 reported that 
the treatment of intrabony defects with intraoral cancellous bone showed new 
attachment of 3.5 mm after 9 months.  
 In Group 2, the mean gain in CAL at the end of 6 months was 2.46 mm. 
Similar result was observed by Xiang-ying et al. (2006) 66 who reported that the 
combined therapy of PRP and xenografts showed attachment gain of 1.67 mm. The 
higher gain compared to xenografts alone can be attributed to the addition of PRP 
which increases the migration and proliferation of the endothelial cells, periodontal 
ligament cells, pre-osteoblasts, osteoblasts and osteoclasts in the surgical site which 
stimulates bone regeneration.78 
  In Group 1 the gain at the end of 6 months was 47.53%. In Group 2, at the end 
of 6 months was 34.54%. There was 12% increase in gain in Group 1 compared to 
Group 2. On comparison between the Groups at different time intervals (3rd and 6th 
months) Group 1 was statistically highly significant with p-value <0.001. It is 
believed that autogenous bone grafts produce pronounced revascularization and 
enhances osteogenesis which resulted in marked gain in the clinical attachment level 
compared to other bone graft materials.8 
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 In Group 1, the depth of the defect at baseline was 7.57 ±0.75 mm. At the end 
of 6 months it was reduced to 4.42±0.53 mm. In the present study, the mean bone fill 
at the 6th month was 3.15 mm. The results concur with previous studies of Forum     
et al. (1975) 35 who reported the mean bone fill of 2.98 mm using bone blending. 
Hiatt and Schallhorn (1975) 37 also observed a mean bone fill of 3.5 mm using intra-
oral cancellous bone in intrabony defects.  
   In Group 2, the depth of defect at baseline was 7.71 ±0.94 mm. At 6 months 
it was reduced to 5.57±0.97 mm. The mean bone fill at the 6th month was 2.14 mm. 
Similar results were shown by Xiang-ying et al. (2006) 66 who reported a mean bone 
fill of 2.20 mm in intrabony defects grafted with xenografts and PRP.  
 In the present study, Group 1 resulted in 46.60% of bone fill at the end of 6th 
month. In Group 2, the bone fill was 27.7% and at the end of 6th month. There was 
19% increased bone fill in Group 1 compared to Group 2 which was statistically 
highly significant with p-value <0.001.  
This is in accordance with Becker et al. (1998) 38 who observed that the healing 
of demineralized bone grafts was delayed due to the retention of non-vital bone 
particles within the host bone. In contrast, autografts heal with vital woven and 
lamellar bone with pronounced osteoclastic and osteoblastic activity. Also the 
demineralized bone grafts was primarily osteoconductive in nature and only act as 
space filler particles in the defect site whereas autogenous bone grafts heals by 
osteogenesis and retains viable osteoblasts.6,8 In the early stages of healing of 
autografts new bone originates from the surviving osteoprogenitor cells and in later 
stages new bone originates from the osteoinduction response of the host bone.36 
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The present study shows overall reduction in the probing pocket depth, marked 
gain in the clinical attachment level and bone fill in both the groups which could be 
attributed to the resolution of tissue inflammation, reconstruction of the supporting 
periodontal structures in terms of alveolar bone, PDL which was in accordance with 
the previous studies by Carraro et al. (1975) 2, Hanna et al. (2004) 20 
Particle size of bone grafts plays an important role which results in greater bone 
fill, greater gain, and improved healing response in Group 1. According to Rivault et 
al. (1971) 32 the thin bone chips of osseous coagulum provides sooner and greater 
osteogenic activity than the thicker particles as found in allografts and xenografts.  
In this study the osseous coagulum obtained using scraper also produces thin 
bone shavings which resulted in more regeneration compared to xenografts. 
According to Weinmann and Sicher (1969) 34 the smaller and thinner particles have 
the advantage of making them readily susceptible to hydrolyzing enzymes which 
dissolve their cementing substances and liberate minerals. These particles also results 
in rapid resorption which can lead to a local rise in calcium concentration and thus 
favour more bone formation.10, 36, 76 
In our study Group 2 (xenograft and PRP) produced less PPD reduction, less 
CAL gain and decreased bone fill compared to Group 1 (autogenous bone grafts). The 
results corroborates the findings of previous studies done by Schlegel et al. (2004) 77 
who have shown that PRP increases bone formation only in the initial stages of 
healing.  
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 Nagata and Melo (2009) 78 also reported that the beneficial effect of PRP was 
limited to an initial healing period of 4 weeks. After 4 weeks the direct influence of 
PRP will fade away and physiological mechanisms of bone repair will continue to 
work according to the type of graft used. 78, 74  
         Thus the regeneration of the periodontal attachment apparatus in the present 
study had a favorable clinical and radiological outcome using both bone replacement 
grafts. While comparing the 2 Groups, statistically highly significant difference 
(p<0.001) was noted in Group 1 regarding the clinical parameters and radiological 
parameters at 3rd and 6th months postoperatively. 
However, limitations of this study include a small sample size and limited time 
frame for post surgical evaluation. In order to evaluate the true regenerative potential 
of the bone graft materials and biologic modifiers (PRP), a study design of larger 
sample size with longer follow-up period (more than 12 months) would be needed. 
Surgical reentry of treated sites would also provide credible data. 
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SUMMARY AND CONCLUSION 
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 The present study involved a comparative clinical and radiographic evaluation 
of regenerative osseous surgery performed with autogenous bone grafts and 
demineralized xenograft (osseograft) combined with PRP. The study population 
comprised of 7 patients age ranging from 20-50 years. All patients returned for 
scheduled maintenance visits. A total of 14 intrabony defects were treated and post 
operative healing in the grafted areas was satisfactory. The following clinical 
parameters like plaque index, gingival index, oral hygiene index (simplified), probing 
pocket depth and clinical attachment levels were assessed at baseline, 3 months and 6 
months. Hard tissue evaluation was done to measure the amount of bone fill in the 
grafted sites using Auto-CAD 2006 software. 
Within the framework of this study, the following conclusions have been elucidated:- 
1. Both Autogenous bone graft and combination of Demineralized Bovine 
derived Xenograft (Osseograft) with PRP, used as regenerative graft 
material in bone grafting yielded favorable clinical results in periodontal 
intrabony defects. 
2. Probing pocket depth and gain in attachment level were significant in both 
Groups compared to their pre-operative levels. 
3. Both the Groups exhibited significant amount of bone fill following 
therapy. But sites grafted with autogenous bone grafts (Group 1) showed 
a statistically highly significant (p<0.001)  amount of bone fill indicative 
of better graft remodeling compared to sites grafted with mixture of 
xenograft and PRP (Group 2) at 3rd and 6th months post operatively. 
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4. Thus when mean scores were compared between Groups at 3rd and 6th 
months post- operatively, there was statistically highly significant 
difference (p<0.001) in Group 1 as far as clinical parameters and 
radiographic measurements were concerned. 
             The results presented here clearly demonstrate that the autogenous bone graft 
and combination of bovine derived xenograft (Osseograft) with PRP has the potential 
to promote predictable periodontal regeneration in the treatment of periodontal 
intraosseous defects. The results also indicate that surgical reconstructive treatment of 
intra-osseous defects with autogenous bone graft (Group 1) resulted in clinically and 
statistically significant higher probing pocket depth reduction, clinical attachment 
level gain and radiographic bone fill compared to xenograft mixed with PRP           
(Group 2).  
         However, it is necessary to have a large sample size and long term well 
controlled clinical trails to evaluate the true efficacy of these materials. Also further 
studies needed to be carried out to confirm the effects of PRP in periodontal 
regeneration. 
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